Renalytix AI plc RENX

An artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease.

With another AIM healthcare stock here with some potential for growth if things go well. Healthcare Equipment & Services sector working with AI, RenalytixAI PLC, is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, which is one of the most common and costly chronic medical conditions globally. Through drawing from distinct sources of patient data, RENX intends to build a deep, unique pool of kidney disease-related data for different AI-enabled applications designed to improve predictive capability and clinical utility over time.

1 Like